Cart
sales@molnova.com
PERK-IN-6
CAS No. 1337532-14-5
PERK-IN-6( —— )
Catalog No. M36418 CAS No. 1337532-14-5
PERK-IN-6 is a novel and highly potent PERK inhibitor (IC50:2.5 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 246 | Get Quote |
|
| 5MG | 375 | Get Quote |
|
| 10MG | 559 | Get Quote |
|
| 25MG | 864 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePERK-IN-6
-
NoteResearch use only, not for human use.
-
Brief DescriptionPERK-IN-6 is a novel and highly potent PERK inhibitor (IC50:2.5 nM).
-
DescriptionPERK-IN-6 (Compound 5) is a PERK inhibitor with an IC50 of 2.5 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetPERK
-
RecptorPERK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1337532-14-5
-
Formula Weight398.46
-
Molecular FormulaC23H22N6O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC1=C2C(=CN(C)C2=NC=N1)C=3C=C4C(=CC3)N(C(CC=5N=C(C)C=CC5)=O)CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Axten JM, et al. Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development. ACS Med Chem Lett. 2013 Aug 12;4(10):964-8.?
molnova catalog
related products
-
Rupestonic acid
Rupestonic acid derivatives have an anti-influenza virus activity, they inhibit IAV by up-regulating HO-1-mediated IFN response.
-
CCT020312
CCT020312 (0-9 μM, 24 h) treatment of medium HT29 cells for 24 h resulted in a concentration-dependent loss of P-S608-pRB signaling with linear response values between 1.8 and 6.1 μM.
-
GCN2-IN-7
GCN2-IN-7 is an orally active, potent and selective inhibitor of the environmental sensing protein GCN2 with anti-tumor activity and can be used to study melanoma.
